MEMPHIS, Tenn., Friday, July 17, 2009 - Duncan-Williams, Inc., (DWI) a Memphis, Tenn.-based financial services firm, announced today that mergermarket has recognized its Equity Capital Markets Health Care research expertise.
mergermarket, an independent Mergers and Acquisitions (M&A) intelligence service, quoted Duncan-Williams' James Terwilliger, Senior Health Care Analyst, concerning IlluminOss Medical's possible sale.
Founded in 2007, IlluminOss Medical, an East Providence, RI medical device company, is currently developing the innovative IllumnOss Photodynamic Bone Stabilization System for orthopedic surgery.
Terwilliger told mergermarket that, “IlluminOss Medical could be very attractive to companies in the orthopedic space."He noted that its concentration on broken bone stabilization could be particularly appealing to companies with orthopedic products that focus on the trauma market and the emergency room. He pointed to Smith and Nephew, Stryker, Zimmer, and Johnston & Johnson as companies that might find IlluminOss Medical of interest."
About Duncan-Williams, Inc.
Duncan-Williams, Inc., is a Top 100 Brokerage Firm headquartered in Memphis, Tenn. The firm is a fullservice brokerage and investment banking firm providing financial solutions to retail and institutional organizations in 50 states and 11 foreign countries. Duncan-Williams, Inc., is a member of FINRA and SIPC. Duncan-Williams, Inc., has offices in New York City, Jersey City, N.J., Chicago, Seattle, Houston, Charlotte, N.C., Philadelphia, PA and Jackson, Miss. The Women’s Business Enterprise National Council certifies Duncan- Williams, Inc., as a Women’s Business Enterprise (WBE). Additional information is available at www.duncanw.com.